| |
| |
|
| Insider
Information: |
Bozigian Haig P. |
| Relationship: |
Chief Development Offi... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
157,651 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$21,544,586 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
157,651 |
|
|
| Total
Value |
$21,544,586 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neurocrine Biosciences Inc |
NBIX |
Chief Development Offi... |
2021-02-08 |
157,651 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-13 |
4 |
AS |
$82.56 |
$1,426,628 |
D/D |
(17,268) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-06-18 |
4 |
AS |
$87.82 |
$184,417 |
D/D |
(2,100) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-10 |
4 |
AS |
$87.63 |
$623,958 |
D/D |
(7,120) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-11 |
4 |
AS |
$87.59 |
$8,759 |
D/D |
(100) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-15 |
4 |
AS |
$87.50 |
$2,684,506 |
D/D |
(30,680) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2019-07-30 |
4 |
AS |
$91.74 |
$4,114,858 |
D/D |
(44,356) |
141,976 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-02-05 |
4 |
AS |
$103.00 |
$210,779 |
D/D |
(2,046) |
143,925 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-02-06 |
4 |
AS |
$101.56 |
$141,670 |
D/D |
(1,395) |
145,180 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-02-07 |
4 |
AS |
$103.33 |
$167,702 |
D/D |
(1,623) |
146,641 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-04-24 |
4 |
AS |
$99.46 |
$192,351 |
D/D |
(1,934) |
148,633 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-05-12 |
4 |
AS |
$114.94 |
$7,075,396 |
D/D |
(61,555) |
148,633 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-08-05 |
4 |
AS |
$118.89 |
$268,324 |
D/D |
(2,257) |
150,663 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2020-11-12 |
4 |
AS |
$90.74 |
$204,806 |
D/D |
(2,257) |
152,694 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2021-02-05 |
4 |
AS |
$113.79 |
$80,109 |
D/D |
(704) |
153,328 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2021-02-08 |
4 |
AS |
$116.78 |
$448,749 |
D/D |
(3,842) |
157,651 |
0 |
% |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2018-02-06 |
4 |
D |
$82.48 |
$75,634 |
D/D |
(917) |
135,997 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Sr Vice President, Development |
• – – |
2008-01-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
247 |
|
- |
|
| NBIX |
Neurocrine Biosciences In... |
CHIEF DEVELOPMENT OFFICER |
• – – |
2014-01-17 |
4 |
OE |
$2.59 |
$77,400 |
D/D |
25,000 |
103,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-12 |
4 |
OE |
$2.59 |
$38,545 |
D/D |
9,998 |
88,577 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-15 |
4 |
OE |
$5.12 |
$12,800 |
D/D |
2,500 |
81,079 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2014-12-17 |
4 |
OE |
$2.59 |
$38,855 |
D/D |
15,002 |
93,581 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2015-01-05 |
4 |
OE |
$5.12 |
$12,800 |
D/D |
2,500 |
81,079 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2015-01-08 |
4 |
OE |
$2.59 |
$77,700 |
D/D |
30,000 |
88,579 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-08-04 |
4 |
OE |
$5.76 |
$317,200 |
D/D |
45,000 |
149,601 |
0 |
- |
|
| NBIX |
Neurocrine Biosciences In... |
Chief Development Officer |
• – – |
2017-09-06 |
4 |
OE |
$8.65 |
$350,138 |
D/D |
26,250 |
140,851 |
0 |
- |
|
92 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
